|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ANZCTR |
|
Last refreshed on:
|
11 June 2018 |
|
Main ID: |
ACTRN12618000353291 |
|
Date of registration:
|
08/03/2018 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Efficacy and safety of Artesunate and Amodiaquine combination for the treatment of uncomplicated Plasmodium falciparum malaria in four sentinel sites of Gash Barka Zone, Eritrea
|
|
Scientific title:
|
Efficacy and safety of Artesunate and Amodiaquine combination for the treatment of uncomplicated Plasmodium falciparum malaria in four sentinel sites of Gash Barka Zone, Eritrea |
|
Date of first enrolment:
|
8/09/2016 |
|
Target sample size:
|
352 |
|
Recruitment status: |
Completed |
|
URL:
|
http://www.anzctr.org.au/ACTRN12618000353291.aspx |
|
Study type:
|
Interventional |
|
Study design:
|
Non-randomised trial
Single group |
|
Phase:
|
Phase 4
|
|
|
Key inclusion & exclusion criteria
|
|
Health Condition(s) or Problem(s) studied
|
|
Malaria
|
|
Intervention(s)
|
|
The aim of the study was to evaluates the efficacy and safety of artesunate+amodiaquine among patients suffering from uncomplicated falciparum malaria treated with a daily oral tablet dose of artesunate 4 mg/kg bw + amodiaquine 10mg/kg for 3 consecutive days. The patients were treated under direct supervision and followed up for 28 days.
|
|
Source(s) of Monetary Support
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|